HapMap‐based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non‐smokers

BACKGROUND: The aim of this study was to evaluate the association between CYP2A13 polymorphisms and lung cancer susceptibility using the HapMap database. METHODS: A case‐control analysis of 532 subjects with lung cancer and 614 controls with no personal history of the disease was performed. The tag...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Feng, Guo, Yonglu, Sun, Qiang, Yang, Leizhou, Gao, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449263/
https://www.ncbi.nlm.nih.gov/pubmed/30807688
http://dx.doi.org/10.1111/1759-7714.12954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449263/
https://www.ncbi.nlm.nih.gov/pubmed/30807688
http://dx.doi.org/10.1111/1759-7714.12954

Ejemplares similares